[ 13 ] reported similar recurrence thrombotic rates (11.1% with high-intensity anticoagulation vs 5.5% in case of standard intensity anticoagulation (HR, 1.97; 95% CI, 0.47-7.89), and the bleeding risk did not reach statistical significance (27.8% vs 14.6%; HR, 2.18; 95% CI, 0.92-5.15).
← all excerpts
Machine learning for predicting thrombotic recurrence in antiphospholipid syndrome.
1
—
—